Evidence map›Paper›PMID 34947934›Full record

ArticleLife (Basel, Switzerland)2021

Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water.

Kristýna Hricová, Magdaléna Röderová, Petr Fryčák, Volodymyr Pauk, Ondřej Kurka, Kristýna Mezerová, Taťána Štosová, Jan Bardoň, David Milde, Pavla Kučová and 1 more

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comprehensive Study of Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  5. Multidrug-ResistantMicroorganisms · 2024
    Article
  6. Enterococci,Microorganisms · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kristýna HricováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.
Magdaléna RöderováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.
Petr FryčákDepartment of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 1192/12, 77900 Olomouc, Czech Republic.ORCID 0000-0003-4316-5844
Volodymyr PaukDepartment of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 1192/12, 77900 Olomouc, Czech Republic.ORCID 0000-0002-1313-2032
Ondřej KurkaDepartment of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 1192/12, 77900 Olomouc, Czech Republic.ORCID 0000-0002-2533-5750
Kristýna MezerováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.ORCID 0000-0002-6715-3162
Taťána ŠtosováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.
Jan BardoňDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.
David MildeDepartment of Analytical Chemistry, Faculty of Science, Palacký University Olomouc, 17. Listopadu 1192/12, 77900 Olomouc, Czech Republic.ORCID 0000-0001-9121-6728
Pavla KučováDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.
Milan KolářDepartment of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic.ORCID 0000-0003-4621-8868
Palacký University Olomouc · CZ

Funding

Czech Health Research Council NV18-05-00340
6 · The paper itself

Abstract

Due to the extensive use of antimicrobial agents in human and veterinary medicine, residues of various antimicrobials get into wastewater and, subsequently, surface water. On the one hand, a combination of processes in wastewater treatment plants aims to eliminate chemical and biological pollutants; on the other hand, this environment may create conditions suitable for the horizontal transfer of resistance genes and potential selection of antibiotic-resistant bacteria. Wastewater and surface water samples (Morava River) were analyzed to determine the concentrations of 10 antibiotics and identify those exceeding so-called predicted no-effect environmental concentrations (PNECs). This study revealed that residues of five of the tested antimicrobials, namely ampicillin, clindamycin, tetracycline, tigecycline and vancomycin, in wastewater samples exceeded the PNEC. Vancomycin concentrations were analyzed with respect to the detected strains of vancomycin-resistant enterococci (VRE), in which the presence of resistance genes, virulence factors and potential relationship were analyzed. VRE were detected in 16 wastewater samples (11%) and two surface water samples (6%). The PNEC of vancomycin was exceed in 16% of the samples. Since the detected VRE did not correlate with the vancomycin concentrations, no direct relationship was confirmed between the residues of this antimicrobials and the presence of the resistant strains.

Indexed as

antimicrobial residuesvancomycin-resistant enterococci (VRE)wastewater

Identifiers

PMID34947934
PMCPMC8706104
OpenAlexW4200526910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.